Table 2.
Site | USC w/ASG [%] | ISC w/ASG [%] | USC w/o ASG [%] |
---|---|---|---|
Head & neck | 1.0 ± 3.5 | 1.1 ± 3.6 | 2.6 ± 10.1 |
Lung | 1.2 ± 1.6 | 1.2 ± 1.4 | 1.4 ± 2.8 |
Pelvic region | 1.1 ± 1.0 | 1.2 ± 1.1 | 3.4 ± 2.1 |
Prostate | 2.0 ± 1.4 | 1.2 ± 1.1 | 2.4 ± 1.8 |
Site | USC w/ASG [%] | ISC w/ASG [%] | USC w/o ASG [%] |
---|---|---|---|
Head & neck | 1.0 ± 3.5 | 1.1 ± 3.6 | 2.6 ± 10.1 |
Lung | 1.2 ± 1.6 | 1.2 ± 1.4 | 1.4 ± 2.8 |
Pelvic region | 1.1 ± 1.0 | 1.2 ± 1.1 | 3.4 ± 2.1 |
Prostate | 2.0 ± 1.4 | 1.2 ± 1.1 | 2.4 ± 1.8 |